Preoperative chemotherapy for bladder cancer: A standard waits to be optimally deployed Editorial Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Cisplatin
  • Deoxycytidine
  • Neoadjuvant Therapy
  • Urinary Bladder Neoplasms

abstract

  • A retrospective study of neoadjuvant gemcitabine plus cisplatin in the current issue of Cancer highlights the activity of this regimen and its low frequency of employment. Directions for the further development of neoadjuvant therapy for bladder cancer are discussed. Copyright © 2011 American Cancer Society.

publication date

  • January 2012

Research

keywords

  • Editorial

Identity

Digital Object Identifier (DOI)

  • 10.1002/cncr.26239

PubMed ID

  • 21732335

Additional Document Info

start page

  • 8

end page

  • 11

volume

  • 118

number

  • 1